Company News
Gujarat Themis Biosyn Acquires MicroBiopharm Japan for ₹1220 Crores
Gujarat Themis Biosyn completed acquisition of MicroBiopharm Japan through subsidiary with total investment of ₹1220 crores.
Acquisition provides precision fermentation capabilities, three GMP plants,